ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Total du passif3.93 B3.88 B3.83 B3.8 B3.92 BTotal des capitaux propres2.37 B2.68 B2.26 B2.38 B2.72 BTotal du passif et des capitaux propres6.3 B6.56 B6.09 B6.18 B6.64 BDette totale1.99 B1.99 B1.99 B1.99 B1.99 BDette nette1.9 B1.92 B1.77 B1.76 B1.77 B
Illumina, Inc. - Common Stock
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.